Companies

Translational Development Acquisition Corp.

TDAC, TDACU, TDACW · CIK 0001926599 · operating

$10.56+0.09%Last updated Mar 2, 4:47 PM

Key Statistics

Valuation

Market Cap$231.34M
P/E48.00
Fwd P/E
PEG
P/S
P/B
EV/EBITDA
EV/Rev

Profitability

Gross Margin
Op. Margin
Net Margin
ROE1.27%
ROA-0.04%
FCF Margin

Financial Health

Current Ratio3.09
Debt/Equity-1.12
Free Cash Flow-$851,446
Div. Yield

Growth & Other

Revenue Growth
EPS Growth
Beta
52W High$10.56
52W Low$10.03

About Translational Development Acquisition Corp.

# Translational Development Acquisition Corp.

Translational Development Acquisition Corp. is a blank-check company incorporated in 2022 and headquartered in New York, NY. The company has no significant operating business and exists primarily to identify and execute a business combination with an unspecified target company. As a special purpose acquisition vehicle (SPAC), it was formed to facilitate the merger, consolidation, or asset acquisition of one or more operating businesses, with the specific target sector or industry not yet determined at the time of its public listing on the Nasdaq.

The company has generated no material revenue streams to date, as it remains in the pre-combination stage with minimal operations. Following completion of a business combination, the resulting entity would assume the operations and business model of its merger partner. As of its current stage, the company maintains a lean structure typical of blank-check vehicles, with operations limited to capital management and target identification activities.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024

Annual Reports (10-K) · 1 filings

Report DateFiledAccession Number
2024-12-312025-03-310001410578-25-000576SEC ↗